Oct 10, 2017
Narcolepsy Market Insights, Epidemiology and Market Forecast 2023 Report will provide an overview of the disease and global market size of the Narcolepsy with historical and foretasted epidemiological data for the prevalent cases of Narcolepsy from 2013 to 2023.

October 10, 2017 /MarketersMedia/ —
Diligent Market is a Business Consultant company and serve as a Knowledge partner across the value chain of Pharmaceutical Industry. With the use of proprietary databases and analytical models, Diligent Market provides cutting-edge data on Narcolepsy market and pipeline analysis and API intelligence, helping clients to quantify Narcolepsy market events and evaluate their impact on the valuation of its products, portfolios and companies.
Narcolepsy is a chronic neurological / brain disorder which involves poor control of sleep and wakefulness. Narcolepsy is classically a tetrad of symptoms including EDS, cataplexy, sleep paralysis, and hypnagogic hallucinations.
Narcolepsy affects approximately 200,000 Americans and 3 million people worldwide. Narcolepsy is not rare, but it is severely under-recognized and commonly misdiagnosed. Narcolepsy appears throughout the world but occurrence rates vary among populations. The occurrence rate of narcolepsy is remarkably lower in Israel and quite higher in Japan compared to the United States. In Europe, the occurrence rate is found to be higher in UK and Germany than other European countries.
"Narcolepsy Epidemiology Insights, 2023" report provides historical as well as forecasted epidemiology of Narcolepsy in the 7MM. Report covers the disease overview including pathophysiology, symptoms, diagnosis, disease management, and current treatment options.
Table of Content of the report -
1. Report Introduction
2. Snapshot of Total Prevalent or Incident cases by 7 MM.
3. Executive Summary - Key Findings.
4. Narcolepsy Overview - Narcolepsy Definition, Pathophysiology, Symptoms and Etiology.
5. Risk Factors Associated with Narcolepsy
6. Disease Burden & Unmet Need in the Market
7. Epidemiology and Patient Populations
• Key Findings
• Key Sources used and Forecast Methodology
• Prevalent Cases and Incident Cases-2015-2025
• Prevalent & Incident Cases by Category-2015-2025
• Age-Specific Prevalent/ Incident Cases of Narcolepsy
• Sex-Specific Prevalent/Incident Cases of Narcolepsy
• Disease Type Specific Prevalent/Incident Cases of Narcolepsy
8. Prevalent & Incident Cases by 7 MM-2015-2025 - Narcolepsy Epidemiology of United States, UK, Germany, France, Spain, Italy and Japan.
9. Key Takeaways
10. Appendix
11. Report Methodology
12. Consulting Services
13. Disclaimer
14. About Us
Avail complete report of 40 pages @ https://www.diligentmarket.com/narcolepsy-epidemiology-insights-to-2023-13780-p.php
Diligent Market also provides a report on pipeline insights, "Narcolepsy -Pipeline Insights, 2017", report provides comprehensive insights of the ongoing therapeutic research and development across Narcolepsy. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Narcolepsy by development stage, therapy type, route of administration and molecule type is also covered in the report. It also has a special feature on the inactive pipeline products in this area.
The report provides a snapshot of the pipeline development for the Narcolepsy. It covers pipeline activity across the complete product development cycle i.e. clinical, pre-clinical and discovery stages for the Narcolepsy. The report provides pipeline product profiles which includes product description, developmental activities, licensors & collaborators and chemical information. Provides pipeline assessment by monotherapy and combination therapy products, stage of development, route of administration, and molecule type for Narcolepsy the report also covers the dormant and discontinued pipeline projects related to the Narcolepsy.
Check complete report @ https://www.diligentmarket.com/narcolepsy-pipeline-insights-2017-11527-p.php with key players like NLS Pharma, Jazz Pharmaceuticals Inc, , Avadel Pharmaceuticals , Taisho Pharmaceutical Co., Ltd. , Balance Therapeutics , Theranexus , Ono Pharmaceutical Co., Ltd. , Orexin receptor modulators: Reset Therapeutics , Heptares Therapeutics Limited, and many more mentioned in it.
Diligent Market also provides a complete combination of market insights, epidemiology and market forecast till 2023 in one report. According to Diligent Market worldwide Narcolepsy will increase at a CAGR of 8.48% during the forecast period 2013-2023. PROVIGIL by Cephalon, Inc and XYREM by Jazz Pharmaceuticals is the top selling drug for Narcolepsy contributing to majority of the market share. Other drugs are also being used for the treatment of Narcolepsy as secondary indication, but do not have much impact on the overall market size.
Report – “Narcolepsy-Market Insights, Epidemiology and Market Forecast-2023” will help in developing business strategies by understanding the trends shaping and driving the Narcolepsy market. It helps in organizing sales and marketing efforts by identifying the best opportunities for Narcolepsy in US, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan. It helps in understanding the future market competition of Narcolepsy therapies in the 7MM and Insightful review of the key market drivers and barriers. The report provides historical as well as forecasted epidemiology of Narcolepsy in the 7MM. Report also gives regulatory scenario in major markets. The Report also covers the detailed historical and forecasted Narcolepsy market covering United States, Europe (Germany, Spain, Italy, France and United Kingdom) and Japan from 2013-2023.
Complete report with description, table of content and list of figures @ https://www.diligentmarket.com/narcolepsy-market-insights-epidemiology-and-market-forecast-2023-13444-p.php
For further information or queries, please contact the Sales Team, Diligent Market at [email protected] / [email protected] or call us at +91 750–707-8687.
Contact Info:
Name: Irfan Tamboli
Organization: Diligent Market
Phone: +91 750–707-8687
For more information, please visit https://www.diligentmarket.com/
Source: MarketersMedia
Release ID: 246303
September’s Consumer Price Index report will keep pressure on President Trump and the Federal Reserve to tame intensifying price pressures.
The final inflation report before the 2026 election — showing price increases and stagnant wages — spelled bad political news for the White House.
In a volatile moment in the region, a significant increase in attacks on vessels passing through the vital waterway is raising alarm.
Confirming the review, the government said it was "vital to ensure travel remains accessible and that passengers are treated fairly".
The streamer’s share price is down more than 40 percent over the last year as the company has struggled with stalling engagement.
The cuts equate to around 6% of the streaming giant's total workforce worldwide.
The police identified the 42-year-old man who died at Six Flags Over Georgia on Monday. The company said it was temporarily closing multiple rides in the U.S. and Canada as a precaution.
US inflation continues to rise, and this month the jump was above forecasts. Here's how some are surviving.
Abdulrahman Alfozan had worked for the AI giant for more than a year before he was arrested by the FBI.
The ruling will allow the outlets to enter the White House grounds while they sue to overturn the ban. But it doesn’t resolve all of their access problems.
China’s exports grew last month at the fastest pace in almost any month since the end of the global financial crisis.
The pace of price rises increased to 3.7% in the year to September, driving by higher motor fuel costs.
YOUR NEWS, OUR NETWORK.
Do you have Great News you want to tell the world?
Be it updates about your business or your community, you can make sure that it’s heard by submitting your story to our network reaching hundreds of news sites across 6 verticals.